Fock Jimy, Galea Mary P, Stillman Barry C, Rawicki Barry, Clark Malcolm
Brighton Rehabilitation Centre, Victoria, Australia.
Brain Inj. 2004 Jan;18(1):57-63. doi: 10.1080/0269905031000149498.
The aim of this study was to assess the effect of Botulinum toxin A in the management of spastic equinus resulting from traumatic brain injury.
A before-after intervention design was used without controls.
Subjects were seven patients suffering from traumatic brain injury of average duration 14 (4-38) months as a result of motor vehicle trauma, who had spastic equinus interfering with gait.
The patients were treated with injections of Botulinum toxin A into the spastic calf muscles: gastrocnemius, soleus and tibialis posterior. Assessments were made pre-injection and at 2 weeks and 3 months post-injection.
At the end of the 3-month period, all patients showed a significant improvement in gait velocity, cadence and stride length.
The findings suggest that Botulinum toxin A may be useful in the management of spastic equinus following traumatic brain injury.
本研究旨在评估A型肉毒杆菌毒素对创伤性脑损伤所致痉挛性马蹄足的治疗效果。
采用无对照的前后干预设计。
研究对象为7例因机动车创伤导致创伤性脑损伤的患者,平均病程14(4 - 38)个月,患有影响步态的痉挛性马蹄足。
对患者痉挛的小腿肌肉(腓肠肌、比目鱼肌和胫后肌)注射A型肉毒杆菌毒素。在注射前、注射后2周和3个月进行评估。
在3个月疗程结束时,所有患者的步态速度、步频和步幅均有显著改善。
研究结果表明,A型肉毒杆菌毒素可能有助于治疗创伤性脑损伤后的痉挛性马蹄足。